Jenscare Scientific Co., Ltd. is a holding company, which engages in the development and sale of transcatheter aortic valve systems. The company is headquartered in Ningbo, Zhejiang and currently employs 174 full-time employees. The company went IPO on 2022-10-10. The firm develops a series of treatment solutions targeting different types of structural heart diseases. The firm's products and pipelines mainly include LuX-Valve, LuX-Valve Plus, Ken-Valve, JensClip, JensRelive, MicroFlux and SimuLock. LuX-Valve is the transcatheter tricuspid valve replacement system designed to treat patients with severe tricuspid regurgitation and high surgical risk. Ken-Valve is the transcatheter aortic valve replacement system designed to treat patients with severe aortic regurgitation or combined with aortic stenosis.
09877.HK stock price ended at $7.99 on 月曜日, after rising 1.27%
On the latest trading day Feb 16, 2026, the stock price of 09877.HK rose by 1.27%, climbing from $8.19 to $7.99. Throughout the session, the stock experienced a volatility of 2.50%, with prices fluctuating between a daily low of $7.99 and a high of $8.19. Alongside this price increase, trading volume also rose by 147.2K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 200 shares were traded, amounting to a market value of approximately $2.4B.